Results 251 to 260 of about 236,205 (303)
Some of the next articles are maybe not open access.

Expression of Fas and Fas Ligand in Hodgkin's Disease

Leukemia & Lymphoma, 1999
Fas and Fas ligand expression were investigated in twenty two cases of classical Hodgkin's disease (HD) by immunohistochemistry. While Reed-Sternberg (RS) cells in 7/22 (32%) cases expressed Fas ligand, reactive lymphoid cells expressed Fas ligand in only 2 (9%) cases. In 20/22 (91%) cases, the RS cells expressed Fas. A higher proportion of RS cells in
S S, Metkar   +5 more
openaire   +2 more sources

Expression of Fas‐Fas Ligand in Murine Testis

American Journal of Reproductive Immunology, 1999
Xu JP, Li X, Mori E, Guo MW, Matsuda I, Takaichi H, Amano T, Mori T. Expression of Fas‐Fas ligand in murine testis. AJRI 1999; 42:381–388 © Munksgaard, CopenhagenPROBLEM: During spermatogenesis, it has been suggested that the number of germ cells to be matured is regulated and restricted through the apoptotic mechanism.
J P, Xu   +7 more
openaire   +2 more sources

Fas/Fas ligand and hematopoietic progenitor cells

Current Opinion in Hematology, 1998
Fas antigen is a receptor that crosslinks with a ligand or antibody initiating a signal transduction cascade that leads to apoptosis. During normal hematopoiesis, Fas antigen is not expressed on CD34+ cells, including premature hematopoietic progenitor cells. Functioning Fas antigen expression is induced by several hematopoietic regulators.
Y, Niho, Y, Asano
openaire   +2 more sources

Targeting the Fas/Fas ligand pathway in cancer

Expert Opinion on Therapeutic Targets, 2005
Fas is a transmembrane receptor that can induce apoptosis after cross-linking with either agonistic antibodies or with Fas ligand (FasL). Although originally described as an important regulator of peripheral immune homeostasis, accumulating evidence suggests that the Fas/FasL system plays an important role in tumour development.
Darren I, O'Brien   +5 more
openaire   +2 more sources

Fas and Fas ligand: lpr and gld mutations

Immunology Today, 1995
Fas ligand (FasL) is a death factor that binds to its receptor, Fas, and induces apoptosis. Two mutations that accelerate autoimmune disease, lpr and gld, are known to correspond to mutations within genes encoding Fas and FasL, respectively. Here, Shigekazu Nagata and Takashi Suda summarize current knowledge of Fas and FasL, and discuss the ...
S, Nagata, T, Suda
openaire   +2 more sources

Metabolic Measurements among Homozygous (fa/fa) Obese, Heterozygous (Fa/fa) Lean and Homozygous (Fa/Fa) Lean Zucker Rat Pups at 17 Days of Age

The Journal of Nutrition, 1994
Factors associated with the development of obesity were compared among obese (fa/fa), heterozygous (Fa/fa) lean and homozygous (Fa/Fa) lean Zucker rats at 17 d of age. Inguinal pad weight, pad-to-body weight ratio and fat cell size were highest in obese pups (fa/fa > Fa/fa > Fa/Fa).
F C, Phillips, M P, Cleary
openaire   +2 more sources

Fas and Fas‐ligand expression in seminomatous testes

APMIS, 1999
Sixteen seminomas with surrounding tissue containing normal and precancerous (cis) seminiferous tubules were examined for the expression of Fas (CD95, APO‐1) and Fas ligand (FasL) (CD95L). This was done by analyzing frozen specimens using immunohistochemistry with antibodies directed against Fas and FasL.
O, Braendstrup, B, Bols, L, Jensen
openaire   +2 more sources

Fas and Fas Ligand Expression in Pancreatic Adenocarcinoma

Pancreas, 2002
Fas and Fas ligand (FasL) mediate apoptosis of tumor cells in immune surveillance, and expression of FasL by tumors may mediate their counterattack on cytotoxic lymphocytes. Both proteins are expressed in most if not all pancreatic carcinoma cell lines, but their study in primary human tumors has been limited.We performed Fas and FasL ...
Nat L, Pernick   +5 more
openaire   +2 more sources

Immunolocalization of FAS and FAS ligand in inflammatory myopathies

Acta Neuropathologica, 2001
Fas/Fas ligand (FasL) interaction can induce apoptosis, have a costimulatory role or act as a mechanism by which cytotoxic T cells produce target cell lysis. We used several commercially available antibodies to study Fas and FasL expression in polymyositis (PM), inclusion body myositis (IBM), dermatomyositis (DM) and normal controls.
J L, De Bleecker   +4 more
openaire   +2 more sources

Soluble Fas and Fas Ligand in Pregnancy

Angiology, 2011
The pathophysiology of pregnancy-induced hypertension and preeclampsia may involve abnormalities in placentation and the Fas/Fas ligand system. Hypothesizing abnormal plasma Fas and Fas ligand in pregnancy-induced hypertension, we recruited 20 hypertensive pregnant women at mean week 15 and 29 at week 30: 18 were studied at both time points.
Velore J, Karthikeyan   +5 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy